Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00500708 · ClinicalTrials.gov registry record
Diagnostic Investigation of Sudden Cardiac Event Risk
A clinical trial, sponsored by CardioDx.
- Completed
- Registry status
- 1,564
- Enrollment target
NCT00500708: Completed study, sponsored by CardioDx.
NCT00500708 is a clinical trial that has completed, run by CardioDx. The registered enrollment target is 1,564 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00500708 has completed, sponsored by CardioDx.
- COMPLETED
- Registry status
- 1,564 participants
- Enrollment target
Study Summary
The overall objective of the DISCERN study is to develop and validate a genomic diagnostic assay to identify patients at increased risk for lethal ventricular arrhythmias and sudden cardiac death (SCD).
Primary Outcome
Genome Wide Association Study (GWAS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,564 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-08-01 |
What the finished NCT00500708 record still lists
NCT00500708 is an observational study that tracks outcomes without assigning an intervention. Its 1,564 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00500708 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00500708 about?
NCT00500708 is a clinical study titled "Diagnostic Investigation of Sudden Cardiac Event Risk". The overall objective of the DISCERN study is to develop and validate a genomic diagnostic assay to identify patients at increased risk for lethal ventricular arrhythmias and sudden cardiac death (SCD).
What is the current status of trial NCT00500708?
This trial is currently completed. The enrollment target is 1,564 participants. The study started on 2007-07. Estimated completion is 2011-08-01.
Who is sponsoring clinical trial NCT00500708?
This trial is sponsored by CardioDx, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06034080 · 1,566 participants · NA
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections
- NCT06881069 · 1,560 participants · NA
Reach Through Equitable Implementation in Utah
- NCT06445946 · 1,572 participants · Phase 4
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia